발행물

전체 논문

95

1

Unraveling the features of gallbladder cancer derived biliary extracellular vesicles: An integration of metabolomics, lipidomics, and miRNA profiling.
Kong M, Hong DH, Yoon N, Jung BH, Hong J, Kim M, Kim TH, Jeong J*, Choi D*, Lee H*
Biochem Biophys Res Commun, 2024.04

2

Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease  modeling, and toxicology testing.
Salas-Silva S, Kim Y, Kim TH, Kim M, Seo D, Choi J, Factor VM, Seo HR, Song Y, Choi GS, Jung YK, Kim K, Lee KG, Jeong J, Shin JH, Choi D
Biomaterials, 2023

3

A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality.
Son SH, Kim MY, Choi S, Kim JS, Lee YS, Lee S, Lee YJ, Lee JY, Lee SE, Lim YS, Ha DH, Oh E, Won YB, Ji CJ, Park MA, Kim B, Byun KT, Chung MS, Jeong J, Choi D, Baek EJ, Cho EH, Kim SB, Je AR, Kweon HS, Park HS, Park D, Bae JS, Jang SJ, Yun CO, Chae JH, Lee JW, Lee SJ, Kim CG, Kang HC, Uversky VN, Kim CG
Advanced Science (Weinh), 2023.11

4

Widespread 8-oxoguanine modifications of miRNA seeds differentially regulate redox-dependent cancer development.
Eom S, Peak J, Cho YK, Ahn SH, Park J, JeongY, Lee HS, Gu D, Ignatova E, Hong Y, Kim GW, Lee DC, Lee J, Lee SE, Hahm JY, Jeong J, Choi D, Jang ES, Chi SW
Nature Cell Biology, 2023.09

5

Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation.
Kim DH, Kim MS, Kang HK, Kim MJ, Choi SW, Ryu J, Kwak SY, Jeong J, Choi D, Kang KS
Nature communications, 2023.02

6

Ex vivo gene therapy with chemically derived hepatic progenitors.
Kim Y, Jeong J*, Choi D*
Methods in Molecular Biology, 2023

7

Current status of therapeutic applications of gene editing in chronic liver diseases.
Shin JH, Lee J, Jung YK, Kim KS, Jeong J*, Choi D*
BMB Reports, 2022.06

8

UPF1 inhibits hepatocellular carcinoma growth through DUSP1/p53 signal pathway.
Lee S, Hwang Y, Kim TH, Jeong J, Choi D, Hwang J
Biomedicines, 2022.03

9

Elimination of reprogramming transgenes facilitates the differentiation of induced pluripotent stem cells into hepatocyte-like cells and hepatic organoids.
Jeong J, Kim TH, Kim M, Jung YK, Kim KS, Shim S, Jang H, Jang WI, Lee SB, Choi D.
Biology (Basel), 2022.03

10

Transplantation of patient-specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cells.
Buisson EM, Park SH, Kang K, Jang K, L JE, Kim YW, Lee NK, Jeong MA, Kang BK, Factor VM, Seo D, Jeong J*, Kim HJ*, Choi D*
Bioengineering and Translational Medicine, 2021